Platelet derived endothelial cell growth factor/thymidine phosphorylase enhanced human IgE production

Allergology International

Volumn 60, Issue 1, 2011, Pages 79-85

  Yamamoto, Hideyuki ^a   Yamada, Takechiyo ^a   Takabayashi, Tetsuji ^a   Sunaga, Hiroshi ^a   Oh, Myungmi ^a   Narita, Norihiko ^a   Kojima, Akihiro ^a   Fujieda, Shigeharu ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

IgE; Platelet derived endothelial cell growth factor (PD ECGF); Thymidine phosphorylase; Thymidine phosphorylase inhibitor (TPI); VEGF

Indexed keywords

2 DEOXY DEXTRO RIBOSE 1 PHOSPHATE; 5 CHLORO 6 [1 (2 IMINOPYRROLIDINYL)METHYL]URACIL HYDROCHLORIDE; GLYCOSYLTRANSFERASE INHIBITOR; IMMUNOGLOBULIN E; INTERLEUKIN 4; MONOCLONAL ANTIBODY; PHOSPHATE; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; STAT6 PROTEIN; THYMIDINE PHOSPHORYLASE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; IMMUNOSTIMULATION; IN VITRO STUDY; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 79952776404     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.10-OA-0220     Document Type: Article

References (37)

1. Wilson JW, Hii S. The importance of the airway microvasculature in asthma. Curr Opin Allergy Clin Immunol 2006; 6:51-5.
2. Li X, Wilson JW. Increased vascularity of the bronchial mucosa in mild asthma. Am J Respir Crit Care Med 1997; 156:229-33.
3. Mori S, Fujieda S, Sunaga H, Fox SB, Saito H. Expression of platelet-derived endothelial cell growth factor and vascularity in the nasal mucosa from allergic rhinitis. Clin Exp Immunol 2000;30:1637-44.
4. Matsune S, Ohori J, Yoshifuku K, Kurono Y. Effect of vascular endothelial growth factor on nasal vascular permeability. Laryngoscope 2010;120:844-8.
5. Lee CG, Link H, Baluk P et al. Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med 2004;10:1095-103.
6. Benson M, Carlsson B, Carlsson LM, Wennergren G, Cardell LO. Increased expression of Vascular Endothelial Growth Factor-A in seasonal allergic rhinitis. Cytokine 2002;20:268-73.
7. Kirmaz C, Ozbilgin K, Yuksel H et al. Increased expression of angiogenic markers in patients with seasonal allergic rhinitis. Eur Cytokine Netw 2004;15:317-22.
8. Yuksel H, Kose C, Yilmaz O et al. Increased expression of tissue vascular endothelial growth factor and foetal liver kinase-1 receptor in seasonal allergic rhinitis and relevance to asthma component. Clin Exp Allergy 2007;37: 1183-8.
9. Ishikawa F, Miyazono K, Hellman U. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 1989;338:557-62.
10. Takabayashi Y, Akiyama SI, Akiba S et al. Clinicopathologic and prognosis significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J Natl Cancer Inst 1996;88:1110-7.
11. Fujieda S, Sunaga H, Tsuzuki H, Tanaka N, Saito H. Expression of platelet-derived endothelial cell growth factor in oral and oropharyngeal carcinoma. Clin Cancer Res 1998;4:1583-90.
12. Brown NS, Jones A, Fujiyama C, Harris AL, Bicknell R. Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors. Cancer Res 2000;60:6298-302.
13. Nishimoto K, Matsune S, Miyadera K et al. The role of thymidine phosphorylase in the pathogenesis of allergic rhinitis. Acta Otolaryngol 2000;120:644-8.
14. Puxeddu I, Ribatti D, Crivellato E, Levi-Schaffer F. Mast cells and eosinophils: A novel link between inflammation and angiogenesis in allergic disease. J Allergy Clin Immunol 2005;116:531-6.
15. Fujieda S, Diaz-Sanchez D, Saxon A. Combined nasal challenge with diesel exhaust particles and allergen induces in vivo IgE isotype switching. Am J Respir Cell Mol Biol 1998;19:507-12.
16. Fujieda S, Iho S, Kimura Y, Yamamoto H, Igawa H, Saito H. Synthetic oligodeoxynucleotides inhibit IgE induction in human lymphocytes. Am J Respir Crit Care Med 2000; 162:232-9.
17. Schwartz EL, Wan E, Wang F-S, Baptiste N. Regulation of expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in human colon carcinoma cells. Cancer Res 1998;58:1551-7.
18. Osawa Y, Iho S, Takauji R et al. Collaborative action of NF-_B and p38 MAPK is involved in CpG DNA-induced IFN-_ and chemokine production in human plasmacytoid dendritic cells. J Immunol 2006;177:4841-52.
19. Fujieda S, Lin YQ, Saxon A, Zhang K. Multiple types of chimeric germ-line Ig heavy chain transcripts in human B cells. J Immunol 1996;157:3450-9.
20. Yamada T, Fujieda S, Yanagi S et al. Protein-tyrosine kinase Syk expressed in human nasal fibroblasts and its effect on RANTES production. J Immunol 2001;166:538-43.
21. Yamada T, Fujieda S, Yanagi S et al. IL-1 induced chemokine production through the association of Syk with TNF receptor-associated factor-6 in nasal fibroblast line. J Immunol 2001;167:283-8.
22. Mori S, Takao S, Ikeda R et al. Thymidine phosphorylase suppresses Fas-induced apoptotic signal transduction independent of its enzymatic activity. Biochem Biophys Res Commun 2002;295:300-5.
23. Matsushita S, Nitanda T, Furukawa T et al. The effect of a thymidine phosphorylase inhibitor on angiogenesis and apoptosis in tumors. Cancer Res 1999;59:1911-6.
24. Ikeda R, Che XF, Ushiyama M et al. 2-Deoxy-D-ribose inhibits hypoxia-induced apoptosis by suppressing the phosphorylation of p38 MAPK. Biochem Biophys Res Commun 2006;342:280-5.
25. Zhang K, Zhang L, Zhu D, Bae D, Nel A, Saxon A. CD40- mediated p38 mitogen-activated protein kinase activation is required for immunoglobulin class switch recombination to IgE. J Allergy Clin Immunol 2002;110:421-8.
26. Yamada T, Zhang K, Yamada A, Zhu D, Saxon A. B lymphocyte stimulator activates p38 mitogen-activated protein kinase in human Ig class switch recombination. Am J Respir Cell Mol Biol 2005;32:388-94.
27. Oakes SA, Candotti F, Johnston JA et al. Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways. Immunity 1996;5:605-15.
28. Takeda K, Tanaka T, Shi W et al. Essential role of Stat6 in IL-4 signalling. Nature 1996;380:627-30.
29. Seki Y, Hayashi K, Matsumoto A et al. Expression of the suppressor of cytokine signaling-5 (SOCS5) negatively regulates IL-4-dependent STAT6 activation and Th2 differentiation. Proc Natl Acad Sci U S A 2002;99:13003-8.
30. Sato T, Saito R, Jinushi T et al. IFN-gamma-induced SOCS-1 regulates STAT6-dependent eotaxin production triggered by IL-4 and TNF-alpha. Biochem Biophys Res Commun 2004;314:468-75.
31. Eda H, Fujimoto K, Watanabe S et al. Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5'-deoxy-5-fluorouridine. Cancer Chemother Pharmacol 1993;32:333-8.
32. Fox SB, Moghaddam A, Westwood M et al. Plateletderived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: an immunohistochemical study. J Pathol 1995;176:183-90.
33. Fujieda S, Zhang K, Saxon A. IL-4 plus CD40 monoclonal antibody induces human B cells _ subclass-specific isotype switch: switching to _1, _3 and _4, but not _2. J Immunol 1995;155:2318-28.
34. Abdel-Rahman AM, el- Sahrigy SA, Bakr SI. A comparative study of two angiogenic factors: vascular endothelial growth factor and angiogenin in induced sputum from asthmatic children in acute attack. Chest 2006;129:266-71.
35. Suzaki Y, Hamada K, Sho M et al. A potent antiangiogenic factor, endostatin prevents the development of asthma in a murinemodel. J Allergy Clin Immunol 2005;116:1220-7.
36. Saadeh C, Saadeh C. Asthma remission in a patient with rheumatoid arthritis while on antiangiogenesis therapy during a rheumatoid arthritis trial demonstrated by forced oscillation and spirometry. J Asthma 2007;44:281-3.
37. Temmink OH, Emura T, de Bruin M, Fukushima M, Peters GJ. Therapeutic potential of the dual-targeted TAS- 102 formulation in the treatment of gastrointestinal malignancies. Cancer Sci 2007;98:779-89.